We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDC
7326
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
-350
Closed -$9K
AAU
7327
DELISTED
Almaden Minerals Ltd
AAU
$0 ﹤0.01%
56
VJET
7328
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$0 ﹤0.01%
18
BKCC
7329
DELISTED
BlackRock Capital Investment Corporation
BKCC
$0 ﹤0.01%
1
MARK
7330
DELISTED
Remark Holdings, Inc.
MARK
$0 ﹤0.01%
26
-1,214
-98% -$26.4K
ARAV
7331
DELISTED
Aravive, Inc. Common Stock
ARAV
$0 ﹤0.01%
39
MRTX
7332
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-280,000
Closed -$13.2M
SALM
7333
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
-2,796
Closed -$10K
ONCT
7334
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-714
Closed -$157K
ONCT
7335
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-72
Closed -$16K
PATI
7336
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
-204
Closed -$4K
PCTI
7337
DELISTED
PCTEL, Inc. Common Stock
PCTI
$0 ﹤0.01%
97
-157
-62% -$688
CTG
7338
DELISTED
Computer Task Group, Inc.
CTG
$0 ﹤0.01%
36
ARCE
7339
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
-10,000
Closed -$228K
CORR
7340
CALL
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-200
Closed -$8K
GHL
7341
CALL
DELISTED
Greenhill & Co., Inc.
GHL
-100
Closed -$3K
CWBR
7342
DELISTED
CohBar, Inc. Common Stock
CWBR
-296
Closed -$38K
APRN
7343
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
-54
Closed -$17K
UFAB
7344
DELISTED
Unique Fabricating, Inc.
UFAB
-32
Closed
EMAN
7345
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
66
CGRN
7346
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$0 ﹤0.01%
2
INFI
7347
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$0 ﹤0.01%
96
SURF
7348
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-2,724
Closed -$30K
YVR
7349
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$0 ﹤0.01%
+22
New +$282
ACGN
7350
DELISTED
Aceragen Inc
ACGN
-421
Closed -$64K

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.